United States · FDA National Drug Code directory
AMLODIPINE and OLMESARTAN medoxomil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-190_bd687a21-be18-439a-8e65-103a15b4a8f8
- Product NDC
- 33342-190
- Form
- TABLET, FILM COATED
- Composition / generic term
- AMLODIPINE and OLMESARTAN medoxomil
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161027
- Source listing expiry
- 20271231
Source-listed ingredients
- AMLODIPINE BESYLATE — 5 mg/1
- OLMESARTAN MEDOXOMIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (33342-190-07) · 33342-190-07
- 90 TABLET, FILM COATED in 1 BOTTLE (33342-190-10) · 33342-190-10
- 10 BLISTER PACK in 1 CARTON (33342-190-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-190-12
- 1000 TABLET, FILM COATED in 1 BOTTLE (33342-190-44) · 33342-190-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →